GSK PLCGG

GSK PLC

367.94MXND
0.000.00%
At close at Dec 11, 21:10 UTC
MXN
No trades
See on Supercharts

GSK1/N fundamentals

Key facts

Market capitalization‪1.36 T‬MXN
Founded
Employees (FY)‪70.21 K‬
CEOEmma N. Walmsley
Websitegsk.com
About

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Ownership
‪‪4.08 B‬‬
Free Float shares
‪‪3.73 B‬‬ (91.51%)
Closely held shares
‪‪346.35 M‬‬ (8.49%)
Free Float shares
‪‪3.73 B‬‬ (91.51%)
Closely held shares
‪‪346.35 M‬‬ (8.49%)
Capital structure
Market cap
‪‪1.36 T‬‬
Debt
‪‪423.12 B‬‬
Minority interest
‪‪−14.62 B‬‬
Cash & equivalents
‪‪84.63 B‬‬
Enterprise value
‪‪1.68 T‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪1.36 T‬‬
Price to earning ratio (P/E)
23.61x
Price to sales ratio (P/S)
1.88x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
23.61x
Price to sales ratio (P/S)
1.88x
Valuation ratios
‪0.00‬
‪0.60‬
‪1.20‬
‪1.80‬
‪2.40‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪7.00‬
‪14.00‬
‪21.00‬
‪28.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−6%‬
‪0%‬
‪6%‬
‪12%‬
‪18%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−80.00 B‬‬
‪0.00‬
‪‪80.00 B‬‬
‪‪160.00 B‬‬
‪‪240.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−80.00 B‬‬
‪0.00‬
‪‪80.00 B‬‬
‪‪160.00 B‬‬
‪‪240.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−80.00 B‬‬
‪0.00‬
‪‪80.00 B‬‬
‪‪160.00 B‬‬
‪‪240.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Commercial Operations
By country
Period: 2023
United States
Rest of World
United Kingdom

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪60.00 B‬‬
‪‪120.00 B‬‬
‪‪180.00 B‬‬
‪‪240.00 B‬‬
Actual
Estimate
Earnings
Next:Feb 05
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪3.50‬
‪7.00‬
‪10.50‬
‪14.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
98.91%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
4.62%
Last payment
3.879
Last ex-date
Nov 14, 2024
Dividend history
‪3.5%‬
‪4.2%‬
‪4.9%‬
‪5.6%‬
‪6.3%‬
2019
2020
2021
2022
2023
‪0.00‬
‪7.00‬
‪14.00‬
‪21.00‬
‪28.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪120.00 B‬‬
‪‪240.00 B‬‬
‪‪360.00 B‬‬
‪‪480.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪300.00 B‬‬
‪‪600.00 B‬‬
‪‪900.00 B‬‬
‪‪1.20 T‬‬
Assets
Liabilities